Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 40
Warning: Undefined variable $count in /home/seniorca/public_html/wp-content/themes/divi-news-child-healthcare/index.php on line 121
Telix Expands Late-Stage Urologic Pipeline with Acquisition of Lightpoint Medical
Telix Pharmaceuticals Limited announced on June 21 it has entered into an agreement to acquire Lightpoint Medical and its SENSEI® radio-guided surgery business. Lightpoint Medical is a technology leader in precision-guided robotic cancer surgery. The company develops and markets miniaturized imaging and sensing tools for advanced intra-operative cancer detection. Lightpoint Medical has developed SENSEI, a miniaturized surgical gamma probe for minimally-invasive and robot-assisted surgery. Telix Pharmaceuticals Limited is a biopharmaceutical company focused on the development and commercialization of diagnostic and therapeutic radiopharmaceuticals. Telix is developing a portfolio of... Read More »
Cosmos Health acquires I.Bikas General Partnership’s Distribution Network
Cosmos Health Inc. announced on June 16 that it acquired I.Bikas General Partnership’s distribution network. I.Bikas General Partnership is a Greek pharmaceutical company that has been operating since 1986. Cosmos Health is acquiring Bikas’s sales and distribution network for pharmaceutical and para-pharmaceutical products. The network, which currently generates an approximate annual turnover of $6.7 million, encompasses 50 pharmacies that cater to the everyday needs of individuals. Cosmos Health Inc. is a global healthcare group that was incorporated in 2009 and is headquartered in Chicago, Illinois. The company is engaged in the importation, exportation, distribution and sale... Read More »
It’s Not Just a Private Equity Game – Traditional Health Systems Are Consolidating, Too
Levin Associates attended AHLA’s Health Care Transactions Conference on April 17-19, 2023, and the insights shared below are from panel discussions our writer observed in person. Healthcare investments among private equity firms have attracted a lot of attention in recent years but they’re far from the only players looking to consolidate the market. Traditional not-for-profit health systems are pursuing mergers and acquisitions too, with an emphasis on cross-market deals. Health systems are facing financial threats. Traditional health systems are looking to develop stronger economies of scale because right now, there is a revenue problem. Hospitals are facing serious financial constraints,... Read More »
GLOSSARY: Key Financial Terms of Private Equity Transactions
Explanations provided by industry experts Glossary of Terms Defined: EBITDA Enterprise Value Income Repair Multiple Scrape percentage Second bite and rollover equity Triple net lease (NNN lease) Quality of earnings (QofE) Value Based Enterprise Value Based Care (VBC) EBITDA EBITDA is an acronym that stands for “earnings before interest, tax, depreciation, and amortization”. EBITDA, therefore, represents the financial results of a company’s activities, with interest costs and interest earned as well as all depreciation being excluded. EBITDA is typically utilized as a financial metric to compare the underlying profitability of a company regardless of its depreciation assumptions and/or... Read More »
A Growing Trend: Health Systems Collaborating with Private Equity
Are traditional health systems and private equity-backed groups natural competitors? Maybe not. Levin Associates’ proprietary deal database, which tracks mergers and acquisitions in real time, shows the fast pace at which both sides have been consolidating the medical marketplace over the past decade. The data also shows a new trend taking hold: Rather than competing against each other, health systems and PE firms are forming partnerships. Many experts in the healthcare industry anticipate this trend is here to stay. Levin Associates attended AHLA’s Health Care Transactions Conference on April 17-19, 2023, and the insights shared below are from panel discussions our writer observed in... Read More »
VSS Capital Partners invests in Olympus Cosmetic Group
VSS Capital Partners announced that it invested in Olympus Cosmetic Group. Financial terms of the private transaction were not disclosed. Olympus Cosmetic Group provides comprehensive cosmetic surgery, dermatological treatments and non-surgical cosmetic procedures. The company is structured as a management services organization. Headquartered in Jacksonville, Florida, Olympus’ doctors provide a complete range of facelift, abdominoplasty, breast augmentation, breast lift, liposuction, injectables, non-surgical aesthetic treatments and body contouring, among others, from state-of-the-art facilities. VSS is a private investment firm that invests in the healthcare, information, business... Read More »
Avanos Medical Announces Agreement to Acquire Diros Technology
Avanos Medical, Inc. announced that it has entered into a definitive agreement to acquire Diros Technology Inc. in Markham, Canada. Diros Technology Inc. is a leading manufacturer of innovative radiofrequency products used to treat chronic pain conditions. Avanos Medical, Inc. is a medical technology company focused on delivering clinically superior breakthrough medical device solutions to improve patients’ quality of life. Headquartered in Alpharetta, Georgia, Avanos is committed to addressing some of today’s most important healthcare needs, such as reducing the use of opioids while helping patients move from surgery to recovery. Avanos develops, manufactures and markets its... Read More »
Vivo Infusion Acquires Specialty Infusion
Vivo Infusion announced on June 20 that it has acquired Specialty Infusion for an undisclosed price. With this acquisition, Vivo Infusion will operate 55 ambulatory infusion centers across ten states. Founded in 2018, Specialty Infusion provides ambulatory infusion and specialty pharmacy services at 14 ambulatory infusion centers in New York, Massachusetts and New Jersey. Vivo Infusion is a provider of infusion and injection care for patients suffering from compromised immune systems, infectious diseases and other medical conditions. Vivo serves communities in Colorado, Florida, Ohio, Oklahoma, Pennsylvania, New Jersey and Texas with plans to expand to additional states. Private equity... Read More »
The Rise Funds: TPG’s Impressive Investment Vehicle
TPG (NASDAQ: TPG) has been incredibly active these last few months. As a global asset management firm with more than $137 billion of assets under management, TPG operates out of 14 offices across the globe. According to its website, it has more than 95,000 employees that serve more than 12 million patients each year. TPG invests across five multi-product platforms: Capital, Growth, Impact, Real Estate and Market Solutions, as well as a myriad of funds such as The Rise Funds. TPG kicked 2023 off with the acquisition of MedQuest Associates, Inc., a provider of on-site diagnostic imaging services that generates annualized revenue of approximately $200 million. This deal was completed as a... Read More »Schedule a demo
Gain access to the best healthcare and long-term care investment intelligence, data, and analysis.
